Moderna Inc rising 26% pre-market-reports 'positive data' on early-stage coronavirus vaccine trial

Discussion in 'Options' started by Nighthawk, May 18, 2020.

  1. Nighthawk

    Nighthawk

    Last price 84,96

    +24,49%

    Options will RocknRolla!


    "Each participant was assigned to receive a 25 microgram, 100 mcg or 250 mcg dose at both vaccinations, with 15 people in each dose group. Study participants received two doses of the potential vaccine via intramuscular injection in the upper arm approximately 28 days apart.

    At day 43, or two weeks following the second dose, levels of binding antibodies in the 25 mcg cohort were at the levels generally seen in blood samples from people who recovered from the disease, the company said. Antibodies in the 100 mcg had antibodies that "significantly exceeded levels" in recovered patients.

    The vaccine also produced neutralizing antibodies against Covid-19 in at least eight participants, the company said. Four participants were assigned to receive a 25 microgram dose, while the other four received 100 mcg. Levels of neutralizing antibodies were at or above levels in blood samples, the company said.
     
    Cuddles and zdreg like this.
  2. Nighthawk

    Nighthawk

    Last trade 93.20; +39,75%
     
  3. never2old

    never2old

    are you buying, selling, shorting, options?

    what is your trade, do post it when it happens?

    thanks
     
  4. ironchef

    ironchef

    Congratulations, you can retire on your SRNE and Moderna call options.

    Me? I just grind it out day after day. :vomit:
     
    guru likes this.